PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24053678-1	2013	BACKGROUND: Raltegravir (Isentress )(RALT) has demonstrated excellent efficacy in both treatment-experienced and naive patients with HIV-1 infection, and is the first strand transfer integrase inhibitor to be approved for use in HIV infected adults worldwide.	Raltegravir Potassium	12-23	ERBB receptor feedback inhibitor 1	Homo sapiens	37-41